Ubiquitin anticorps
-
- Antigène Voir toutes Ubiquitin Anticorps
- Ubiquitin
-
Reactivité
- Chemical
-
Hôte
- Souris
-
Clonalité
- Monoclonal
-
Conjugué
- Cet anticorp Ubiquitin est non-conjugé
-
Application
- Western Blotting (WB), Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunoprecipitation (IP), Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunoassay (IA)
- Stérilité
- 0.2 μm filtered
- Clone
- Ubi-1
- Top Product
- Discover our top product Ubiquitin Anticorps primaire
-
-
- Indications d'application
- For immunohistology, immunofluorescence and Western blotting dilutions to be used depend on detection system applied. It is recommended that users test the reagent and determine their own optimal dilutions. The typical starting working dilution is 1:10. For Western blotting it is recommended to use lysis buffer in 10 mM N-ethylmaleimide (e.g. Pierce #23030) to inhibit ubiquitin-conjugating enzymes. N-ethylmaleimide inactivates certain enzymes by blocking free sulfhydryls. After eletrophoresis and transfer, pre-incubate transferred membranes in denaturing buffer (6 M guanidine-HCl, 20 mM Tris-HCl, 5 mM beta-mercaptoethanol, 1 mM PMSF ( pH 7.5)) for 30-60 minutes at 4 °C, followed by extensive PBS washing.
- Restrictions
- For Research Use only
-
- Buffer
- PBS, containing 0.02 % sodium azide and 0.1 % bovine serum albumin.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- 4 °C
- Stockage commentaire
- Product should be stored at 4 °C. Under recommended storage conditions, product is stable for one year.
- Date de péremption
- 12 months
-
-
The Gln-Ala repeat transcriptional activator CA150 interacts with huntingtin: neuropathologic and genetic evidence for a role in Huntington's disease pathogenesis." dans: Proceedings of the National Academy of Sciences of the United States of America, Vol. 98, Issue 4, pp. 1811-6, (2001) (PubMed).
: "Cyclopentenone prostaglandins of the J series inhibit the ubiquitin isopeptidase activity of the proteasome pathway." dans: The Journal of biological chemistry, Vol. 276, Issue 32, pp. 30366-73, (2001) (PubMed).
: "
-
The Gln-Ala repeat transcriptional activator CA150 interacts with huntingtin: neuropathologic and genetic evidence for a role in Huntington's disease pathogenesis." dans: Proceedings of the National Academy of Sciences of the United States of America, Vol. 98, Issue 4, pp. 1811-6, (2001) (PubMed).
-
- Antigène
- Ubiquitin
- Autre désignation
- Ubiquitin (Ubiquitin Produits)
- Synonymes
- anticorps CG11624, anticorps DmUb, anticorps DmUbi-p63E, anticorps Dmel\\CG11624, anticorps Ub, anticorps Ubi-P63e, anticorps Ubi-p, anticorps Ubi63E, anticorps Ubi63p, anticorps Ubip, anticorps Ubiq, anticorps Ubp, anticorps ubi, anticorps ubi-p63E, anticorps ubi63E, anticorps CG18282, anticorps CG32744, anticorps CR32744, anticorps DmUbi-p5E, anticorps Dmel\\CG32744, anticorps ubiquitin, anticorps si:dz180g5.5, anticorps si:busm1-180g5.5, anticorps LOC100194618, anticorps UBIQ, anticorps Ubiquitin, anticorps LOC100282068, anticorps Ubiquitin-63E, anticorps Ubiquitin-5E, anticorps transmembrane and ubiquitin-like domain containing 2, anticorps polyubiquitin, anticorps Putative ubiquitin family protein, anticorps ubiquitin, anticorps ubiquitin B, anticorps UBiQuitin, anticorps Ubiquitin, anticorps Ubi-p63E, anticorps Ubi-p5E, anticorps tmub2, anticorps LOC100194618, anticorps pco110026, anticorps LOC100135798, anticorps UBB, anticorps ubq-1, anticorps LOC100190766
- Classe de substances
- Chemical
- Sujet
- The monoclonal antibody Ubi-1 recognizes ubiquitin, both conjugated and unconjugated. Ubiquitin is a highly conserved globular 76 amino acid protein of about 8.5 kDa. It has an important role in the targeting of proteins for proteolytic degradation. Proteins to be degraded are covalently coupled to the C-terminus of ubiquitin by means of ubiquitin ligases. The ubiquitin itself is frequently also ubiquitinated, producing a polyubiquitin chain. The polyubiquitinated complex is then recognized by a complex of degradative enzymes which form the proteosome. Ubiquitin is also covalently attached to a variety of other pathological inclusions seen in human diseases which appear to be resistant to normal degradation. These inclusions include the neurofibrillary tangles of Alzheimer's disease and progressive supranuclear palsy, Pick bodies of Pick's disease, Lewy bodies of Parkinson's disease, Mallory bodies of alcoholic liver disease, Rosenthal fibers of Alexander's disease, and the inclusion bodies in inclusion myositis and oculopharyngeal muscular dystrophy. The ubiquitin molecule appears to be present in all eukaryotic cells and has an identical primary structure in all animals. Reactivity has been shown in human, bovine, chicken, Drosophilia and C. elegans. Ubiquitin is present in the nucleus, cytoplasm and on cell surface membranes. The monoclonal antibody Ubi-1 was raised against purified bovine ubiquitin conjugated with glutaraldehyde to keyhole limpet hemocyanin.
- Pathways
- Mitotic G1-G1/S Phases, Ubiquitin Proteasome Pathway
-